Literature DB >> 12787017

The experience of dysphagia and its effect on the quality of life of patients with oesophageal cancer.

E Watt1, F Whyte.   

Abstract

This qualitative study was designed to explore the experience of dysphagia in oesophageal cancer and how this impacts on quality of life. The aim of the study was to add to the knowledge and comprehension of this poorly understood symptom. Data was collected through in-depth interview and administration of the EORTC QLQ-C30 and EORTC QLQ-OES24 quality of life tools with six people with incurable oesophageal cancer who had dysphagia. The interviews were tape-recorded and then transcribed verbatim for each participant. Through a thematic analysis of the interview data and a descriptive analysis of the questionnaires a detailed description of the experience of dysphagia and its impact on quality of life was obtained. Five basic themes emerged from the participant's accounts and these were recognizing dysphagia, the physical experience, the emotions evoked, the impact on social life and dysphagia and treatment. In conclusion dysphagia is a troublesome symptom which affects all aspects of quality of life.

Entities:  

Mesh:

Year:  2003        PMID: 12787017     DOI: 10.1046/j.1365-2354.2003.00376.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  9 in total

1.  Palliative radiotherapy and chemoradiotherapy in stage IVA/B esophageal cancer patients with dysphagia.

Authors:  Terufumi Kawamoto; Keiji Nihei; Keisuke Sasai; Katsuyuki Karasawa
Journal:  Int J Clin Oncol       Date:  2018-07-31       Impact factor: 3.402

2.  Overall survival and self-reported fatigue in patients with esophageal cancer.

Authors:  M C Stauder; Y Romero; B Kabat; P J Atherton; D Geno; C Deschamps; A Jatoi; J A Sloan; M Botros; K W Jung; A S Arora; R C Miller
Journal:  Support Care Cancer       Date:  2012-07-29       Impact factor: 3.603

3.  Radiotherapy versus stenting in treating malignant dysphagia.

Authors:  Hany Eldeeb; Hend Ahmed El-Hadaad
Journal:  J Gastrointest Oncol       Date:  2012-12

4.  Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study.

Authors:  Robert C Miller; Pamela J Atherton; Brian F Kabat; Mary B Fredericksen; Debra M Geno; Claude Deschamps; Aminah Jatoi; Jeff A Sloan; Yvonne Romero
Journal:  Dig Dis Sci       Date:  2010-01-22       Impact factor: 3.199

5.  Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?

Authors:  Karin Ribi; Dieter Koeberle; Jan C Schuller; Hanspeter Honegger; Arnaud Roth; Viviane Hess; Peter Moosmann; Roger von Moos; Markus Borner; Norbert Lombriser; Bernhard Pestalozzi; Thomas Ruhstaller
Journal:  Support Care Cancer       Date:  2009-02-07       Impact factor: 3.603

6.  Prognostic factors for the survival of patients with esophageal cancer in Northern Iran.

Authors:  Mahmood Reza Ghadimi; Mahboobeh Rasouli; Mahmood Mahmoodi; Kazem Mohammad
Journal:  J Res Med Sci       Date:  2011-10       Impact factor: 1.852

7.  The impact of chemosensory and food-related changes in patients with advanced oesophagogastric cancer treated with capecitabine and oxaliplatin: a qualitative study.

Authors:  Yfke C de Vries; Esther Helmich; Matty D A Karsten; Sanne Boesveldt; Renate M Winkels; Hanneke W M van Laarhoven
Journal:  Support Care Cancer       Date:  2016-02-27       Impact factor: 3.603

8.  Quality of life measurements as an indicator for timing of support after oesophagectomy for cancer: a prospective study.

Authors:  Marlene Malmström; Rosemarie Klefsgard; Bodil Ivarsson; Maria Roman; Jan Johansson
Journal:  BMC Health Serv Res       Date:  2015-03-12       Impact factor: 2.655

9.  Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT.

Authors:  Douglas Adamson; Jane Blazeby; Catharine Porter; Christopher Hurt; Gareth Griffiths; Annmarie Nelson; Bernadette Sewell; Mari Jones; Martina Svobodova; Deborah Fitzsimmons; Lisette Nixon; Jim Fitzgibbon; Stephen Thomas; Anthony Millin; Tom Crosby; John Staffurth; Anthony Byrne
Journal:  Health Technol Assess       Date:  2021-05       Impact factor: 4.014

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.